Dynavax Technologies Corporation Forecast, price target & analysts
Dynavax Technologies Corporation Target price 2025 - Analyst rating & recommendation
Dynavax Technologies Corporation Classifications & Recommendation:
Dynavax Technologies Corporation Price Target
| Target Price | $24.75 |
| Price | $10.82 |
| Potential |
128.74%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Dynavax Technologies Corporation 2026 .
The average Dynavax Technologies Corporation target price is $24.75.
This is
128.74%
register free of charge
$33.00
204.99%
register free of charge
$10.00
7.58%
register free of charge
|
|
| A rating was issued by 5 analysts: 4 Analysts recommend Dynavax Technologies Corporation to buy, 0 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Dynavax Technologies Corporation stock has an average upside potential 2026 of
128.74%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 277.25 | 326.56 |
| 19.36% | 17.79% | |
| EBITDA Margin | 1.42% | 8.12% |
| 112.30% | 472.84% | |
| Net Margin | 9.05% | 13.23% |
| 435.12% | 46.19% |
5 Analysts have issued a sales forecast Dynavax Technologies Corporation 2025 . The average Dynavax Technologies Corporation sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Dynavax Technologies Corporation 2025 . The average Dynavax Technologies Corporation EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Dynavax Technologies Corporation Analysts have issued a net profit forecast 2025. The average Dynavax Technologies Corporation net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.20 | 0.34 |
| 500.00% | 70.00% | |
| P/E | 31.42 | |
| EV/Sales | 2.65 |
5 Analysts have issued a Dynavax Technologies Corporation forecast for earnings per share. The average Dynavax Technologies Corporation EPS is
This results in the following potential growth metrics and future valuations:
Dynavax Technologies Corporation...
Current Dynavax Technologies Corporation Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Apr 17 2025 |
| Citizens Capital Markets |
Locked
➜
Locked
|
Locked | Feb 21 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Feb 21 2025 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Feb 11 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 14 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 08 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Oct 15 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Apr 17 2025 |
|
Locked
Citizens Capital Markets:
Locked
➜
Locked
|
Feb 21 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Feb 21 2025 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Feb 11 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 14 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 08 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Oct 15 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
